Physician profile
Timothy Miller
NPI 1265439947
$4,055.35
in general payments reported to CMS, 2019-2025
21 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2021: $48.05 · 2022: $1,878 · 2023: $226 · 2024: $1,206 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Travel and Lodging: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.31 |
| Travel and Lodging | $252.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,873.75 | 2022-2025 | Intracept, Intracept Rf Probe, Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $256.87 | 2023-2025 | Sprint Pns System |
| Nevro Corp. | $190.59 | 2019-2024 | Senza |
| Medtronic USA, INC. | $157.86 | 2019 | |
| Pfizer INC. | $83.37 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $73.22 | 2022 | |
| Biodelivery Sciences International, INC. | $69.94 | 2019-2021 | |
| Daiichi Sankyo INC. | $64.38 | 2019-2023 | Injectafer |
| Vertex Pharmaceuticals Incorporated | $49.77 | 2025 | |
| Abbott Laboratories | $47.68 | 2024-2025 | Proclaim |
| Averitas Pharma INC. | $28.64 | 2023 | Qutenza |
| Spinal Simplicity, LLC | $22.86 | 2023 | Ha Minuteman G3-R |
| Lundbeck LLC | $19.20 | 2025 | Vyepti |
| Globus Medical, INC. | $19.13 | 2025 | Senza |
| Medtronic, INC. | $15.97 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $14.93 | 2025 | Rezzayo |
| Vertos Medical, INC. | $14.54 | 2024 | Mild Device Kit |
| Si-Bone, INC. | $13.76 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.74 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.38 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.